Last reviewed · How we verify

NCT03429400

Study of Oral Morphine Sulfate Administration in Pediatric Subjects

Completed Phase 3 Last updated 26 September 2019
What this trial tests

Phase 3 trial testing Morphine Sulfate in Pain, Postoperative in 51 participants. Completed in 29 May 2019.

Timeline
17 April 2018
Primary endpoint
29 May 2019
29 May 2019

Quick facts

Lead sponsorWest-Ward Pharmaceutical
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment51
Start date17 April 2018
Primary completion29 May 2019
Estimated completion29 May 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

West-Ward Pharmaceutical — full company profile →

Who can join

Adults 2 to 17, any sex, with Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a multicenter, open-label study to evaluate the safety and PK of oral morphine sulfate in pediatric subjects with post-operative pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Morphine Sulfate

Trials testing the same drug.

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

Other West-Ward Pharmaceutical trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03429400.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing